Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said on Tuesday. Under …
Bridge Specialty Group Launches Personal Lines Digital Marketplace
Personal lines wholesaler Bridge Specialty Group has launched a new personal lines digital marketplace. Bridge Specialty Group worked with Markel to make its excess and